| 发明名称 |
ORAL FORMULATIONS CONTAINING HYALURONIC ACID FOR SUSTAINED DRUG RELEASE |
| 摘要 |
The present invention discloses a tablet or a capsule for oral administration comprising 0.5-0% (w/w) hyaluronic acid or a salt thereof, an active pharmaceutical ingredient (API), and a coating. |
| 申请公布号 |
US2014302131(A1) |
申请公布日期 |
2014.10.09 |
| 申请号 |
US201214342486 |
申请日期 |
2012.08.31 |
| 申请人 |
Dall Ole Moeller |
发明人 |
Dall Ole Moeller |
| 分类号 |
A61K9/48;A61K31/135;A61K9/20 |
主分类号 |
A61K9/48 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A tablet or a capsule comprising
a) 0.5-50% (w/w) hyaluronic acid or a salt thereof, b) an active pharmaceutical ingredient (API), and c) a coatingfor use in oral administration. |
| 地址 |
Frederiksberg DK |
